share_log

MangoRx Launches 'PRIME' By MangoRx, Powered By Kyzatrex FDA Approved Oral Testosterone Replacement Therapy Treatment

MangoRx Launches 'PRIME' By MangoRx, Powered By Kyzatrex FDA Approved Oral Testosterone Replacement Therapy Treatment

MangorX 推出 MangorX 的 “PRIME”,由 Kyzatrex FDA 批准的口服睾丸激素替代疗法提供支持
Benzinga ·  03/12 09:09
The Dallas Based, Direct-to-Consumer Telemedicine Company Brings the FDA-Approved Oral Testosterone Replacement Therapy Treatment to the Telehealth Market
这家总部位于达拉斯的直接面向消费者的远程医疗公司将经美国食品药品管理局批准的口服睾丸激素替代疗法引入远程医疗市场
Dallas, Texas, March 12, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ:MGRX) ("MangoRx" or the "Company"), a company focused on developing, marketing, and selling a variety of men's health and wellness products via a secure telemedicine platform, including its uniquely formulated hair growth product ('GROW') and erectile dysfunction (ED) drug ('Mango'), is excited to announce the highly anticipated release and availability of 'PRIME' by MangoRx, Powered by Kyzatrex ("PRIME") bringing the FDA-approved oral testosterone replacement therapy (TRT) treatment to consumers...
得克萨斯州达拉斯,2024年3月12日(GLOBE NEWSWIRE)——Mangoceuticals, Inc.(纳斯达克股票代码:MGRX)(“Mango...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发